The VAI status indicates that there are no such complying issues with the facility; hence, the USFDA will not take any regulatory or administrative action against the facility.

Because, frankly, from the sea to reclaimed quarries and mountainside lakes, cold water swimming provides an exhilarating surge of adrenaline, and much-needed variation to your training once the ...

Bronchitis generally gets better on its own without treatment. A sick person sneezes, coughs, or blows their nose near you, exposing you to viral airborne droplets. You touch your nose, eyes, or mouth ...

Cipla's (EMEU BU) 'Take Charge – I Pledge' campaign engaged 4,350 doctors across six countries, setting a new benchmark in raising COPD awareness. This achievement has been recognised by the Asia Book ...

Cipla Q3 results review: The shares of the third largest pharmaceutical firm Cipla rose 2.44 per cent at Rs 1,454.20 a piece on the BSE intraday after the company delivered a solid quarterly earnings ...

Cipla has been helping extend the reach of affordable life-saving HIV/AIDS medications since 2001. The company supplies antiretroviral (ARV) medicines to 64 countries by mostly participating in the ...

39,001 people played the daily Crossword recently. Can you solve it faster than others?39,001 people played the daily Crossword recently. Can you solve it faster than others? New bird flu variant ...

Shares of drugmaker Cipla Ltd. surged to the day's high, gaining as much as 4% after the company's December quarter results. The results were a beat across parameters.

Cipla is awaiting regulatory approval for its gAbraxane product, used in cancer treatment, and hopes to launch it in H2FY26, which could provide a significant boost to its portfolio. However, the ...

HYDERABAD/BENGALURU (Reuters) -Cipla, one of India's largest drugmakers by sales, reported a bigger-than-expected third-quarter profit on Tuesday helped by strong domestic demand, and said the U.S ...

Drug major Cipla reported a 49% year-on-year jump in its December quarter consolidated net profit, reaching Rs 1,571 crore, compared to Rs 1,056 crore in the same period last year. The profit after ...

Cipla Ltd.'s consolidated net profit rose 49% year-on-year in the third quarter of the current financial year, beating analysts' estimates by a substantial margin. The drugmaker posted a consolidated ...